Published in J Immunol on August 01, 1995
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci (2012) 2.01
Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clin Cancer Res (2008) 1.52
Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol (2000) 1.32
Glial connexins and gap junctions in CNS inflammation and disease. J Neurochem (2008) 1.17
Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. J Neurochem (2005) 1.00
Towards a transcriptome definition of microglial cells. Neurogenetics (2004) 0.93
Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex. Brain Behav Immun (2006) 0.80
The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment. Proc Natl Acad Sci U S A (1999) 0.77
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation (2016) 0.75
Expression of CD54 (intercellular adhesion molecule-1) and the beta 1 integrin CD29 is modulated by a cyclic AMP dependent pathway in activated primary rat microglial cell cultures. Inflammation (1998) 0.75
Room-temperature ultraviolet nanowire nanolasers. Science (2001) 9.79
Immune function of astrocytes. Glia (2001) 4.05
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. J Mol Biol (1979) 2.51
Regulation of plasma membrane recycling by CFTR. Science (1992) 2.50
Cloning and expression of a receptor for an insecticidal toxin of Bacillus thuringiensis. J Biol Chem (1995) 2.49
Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem J (1978) 2.46
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci (1996) 2.20
Forest ecosystem development in post-mining landscapes: a case study of the Lusatian lignite district. Naturwissenschaften (2001) 2.17
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood (1997) 1.89
Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol (1990) 1.89
Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med (1988) 1.79
Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem (1999) 1.68
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol (1999) 1.67
An alternative hypothesis of cellular transport of lysosomal enzymes in fibroblasts. Effect of inhibitors of lysosomal enzyme endocytosis on intra- and extra-cellular lysosomal enzyme activities. Biochem J (1978) 1.67
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer (2009) 1.62
Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol (1999) 1.58
CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res (1992) 1.57
Expression and polarized targeting of a rab3 isoform in epithelial cells. J Cell Biol (1994) 1.50
Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med (1990) 1.48
Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol (1990) 1.47
Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol (1999) 1.46
Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem (2000) 1.45
A new polymorph of N-phenyl-phthalimide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.43
New concepts in necrotizing enterocolitis. Curr Opin Pediatr (2001) 1.41
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia (2004) 1.40
Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem (2000) 1.40
Latitudinal population differentiation in two species of Solidago (Asteraceae) introduced into Europe. Am J Bot (1998) 1.40
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney. J Cancer Res Clin Oncol (1997) 1.38
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci U S A (1986) 1.37
Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1989) 1.36
Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci (1999) 1.34
Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol (2000) 1.32
Primary structure of the uracil transport protein of Saccharomyces cerevisiae. Eur J Biochem (1988) 1.31
TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol (1997) 1.27
Auditory sustained attention is a marker of unilateral spatial neglect. Neuropsychologia (1997) 1.24
Evaluating the impact of hospitalists. Ann Intern Med (1999) 1.21
Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med (2001) 1.21
ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J Immunol (2000) 1.21
Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension (1988) 1.19
Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J Neurovirol (1999) 1.17
Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest (1998) 1.17
Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Clin Pharmacol Ther (1983) 1.16
Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther (1994) 1.16
The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol (1996) 1.16
Candida and "20th-century disease". CMAJ (1985) 1.15
Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci U S A (1994) 1.14
Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol (1995) 1.14
Automated examination notification of emergency department images in a picture archiving and communication system. J Digit Imaging (2001) 1.14
Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors. Proc Natl Acad Sci U S A (1983) 1.14
Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions. Nature (1982) 1.12
Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer (2001) 1.11
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol (2001) 1.11
Citation characteristics of research published in Emergency Medicine versus other scientific journals. Ann Emerg Med (2001) 1.11
Risk factors for adverse drug reactions--epidemiological approaches. Eur J Clin Pharmacol (1990) 1.11
Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med (1991) 1.10
Expression of opioid peptides in tumors. N Engl J Med (1987) 1.09
Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J Biol Chem (1992) 1.08
Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol (1992) 1.08
Differential regulation and function of Fas expression on glial cells. J Immunol (2000) 1.08
Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta. Eur J Immunol (1998) 1.07
The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene (2009) 1.07
Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol (2001) 1.07
Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization. Proc Natl Acad Sci U S A (1982) 1.07
Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. J Immunol (1996) 1.07
Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. J Mol Biol (1981) 1.06
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes. J Immunol (1999) 1.05
Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci (1988) 1.05
Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol (1994) 1.05
Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun (1990) 1.04
Noncyclic crown-type polyethers, pyridinophane cryptands, and their alkali metal ion complexes: synthesis, complex stability, and kinetics. J Am Chem Soc (1977) 1.04
Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature (1986) 1.04
Active therapy for chronic low back pain: part 2. Effects on paraspinal muscle cross-sectional area, fiber type size, and distribution. Spine (Phila Pa 1976) (2001) 1.03
Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg Med Chem Lett (2001) 1.03
Activation of DeltaF508 CFTR in an epithelial monolayer. Am J Physiol (1998) 1.03
Influence of age and duration of symptoms on fibre type distribution and size of the back muscles in chronic low back pain patients. Eur Spine J (2000) 1.03
Distinct functional properties of Rab3A and Rab3B in PC12 neuroendocrine cells. J Biol Chem (1996) 1.03
Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr Res (2001) 1.02
The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene (1999) 1.02
Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla. Science (1983) 1.02
Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. J Mol Biol (1982) 1.02
Induction of drug metabolizing enzymes by sulfinpyrazone. Eur J Clin Pharmacol (1981) 1.02
IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J Immunol (2001) 1.02
IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. J Immunol (2000) 1.01
CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol (2001) 1.01
Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol (1987) 1.01
Novel peptide neuronal system in rat brain and pituitary. Science (1981) 1.01
Antibodies specific for alpha-N-acetyl-beta-endorphins: radioimmunoassays and detection of acetylated beta-endorphins in pituitary extracts. J Neurochem (1982) 1.00
Risk factors as reflected by an intensive drug monitoring system. Agents Actions Suppl (1990) 1.00
Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol (1991) 1.00
Image reconstructions with the rotating RF coil. J Magn Reson (2009) 1.00
Colocalization of alpha-neo-endorphin and dynorphin immunoreactivity in hypothalamic neurons. Biochem Biophys Res Commun (1981) 1.00
Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res (2001) 0.99
The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J Immunol (2001) 0.99